← Open Payments lookup

JESSICA BROWN: Open Payments

NPI 1003329236 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$327 in 14 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $835 · 2025 $327

Food & beverage: $327
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.3$74
Abbott Laboratories1$59
Amgen Inc.3$48
PFIZER INC.2$39
Alnylam Pharmaceuticals Inc.1$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Boston Scientific Corporation1$19
Novartis Pharmaceuticals Corporation1$19
GlaxoSmithKline, LLC.1$16

Products named: CARDIOMEMS, Kerendia, REPATHA, ONPATTRO, JARDIANCE, Adempas, VYNDAQEL, WATCHMAN FLX.

Industry payments across TX — which companies pay providers there.